| Value | ₹1.96 Cr |
|---|
BSE filing, BSE: 543963. Summary written from the filing by ALFA Finder's alert engine.
Shelter Pharma Ltd: key numbers
- Share price
- ₹39.60
- Market cap
- ₹68.52 Cr
- Revenue (annual)
- ₹73.13 Cr
- Net profit (annual)
- ₹9.03 Cr
- P/E (TTM)
- 7.6×Sector 46.5×
- Promoter holding
- 46.11%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Shelter Pharma Ltd
All →Shelter Pharma Other Announcement
Shelter Pharma Ltd filed its shareholding pattern under Regulation 31(1)(c). The filing reports promoter, public and category-wise holdings without any transaction.
Shelter Pharma Convertible Warrants
Shelter Pharma Limited approved the conversion of 465,000 warrants into equity shares for its promoter. This allotment follows the receipt of the remaining exercise price of Rs. 1.47 Crore.
- Value
- ₹1.47 Cr
Shelter Pharma Other Announcement
Shelter Pharma Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026. This is a routine regulatory compliance disclosure.
Shelter Pharma Management Change
Shelter Pharma Limited has regularized Ms. Vinita Shivraj Gadhavi as a Non-Executive Independent Director for a five-year term, following approval by shareholders at the 19th AGM.
Shelter Pharma Annual General Meeting
Shelter Pharma Limited conducted its 19th Annual General Meeting on September 29, 2026. Key agenda items included adopting financial statements and ratifying material related party transactions.
Shelter Pharma Bags ₹0.1 Cr Order from Berlin International Company
Shelter Pharma received a ₹0.10 Cr export order from Berlin International Company for D3 CURE nutraceuticals. The order broadens its global nutraceutical customer base.
- Value
- ₹0.10 Cr
- From
- Berlin International Company
- Execution
- mutually agreed timelines as per purchase order schedule
Other preferential issue announcements
All →CCME Global Preferential Issue
CCME Global's Preferential Issue Committee allotted about 15.08 crore equity shares worth Rs 150.84 crore, including shares for cash and for acquiring stakes in CCME UAE and Interlink. Both entities become associate and subsidiary respectively from October 28, 2026.
- Value
- ₹150.8 Cr
Sharp Investments Preferential Issue
Sharp Investment disclosed that its proposed preferential issue is solely to acquire 100% of RLCPL via share swap. The shares carry a nominal Rs.1 face value with no cash consideration.
Avalon Technologies Preferential Issue
Avalon Technologies intimated an EGM on 21 Nov 2026 seeking approval for AoA alterations and a preferential issue of 19,37,808 warrants to Zollner Elektronik AG. The warrants aggregate about ₹425 Crore at ₹2,193.20 each.
- Value
- ₹425.0 Cr
- Execution
- Warrants exercisable for 18 months from allotment
Kuber Udyog Preferential Issue
Kuber Udyog's board approved allotting equity shares and warrants on preferential basis, valued at 276.13 Crore. A share swap acquires 100% of Golden Ikon Fleet Management.
- Value
- ₹276.1 Cr
ACI Infocom Preferential Issue
ACI Infocom allotted 3.2 crore shares and 10 crore warrants to Sanjay & Rupal Mandavia at ₹1.53 each, a ~₹20.20 Crore preferential issue.
- Value
- ₹20.20 Cr
Sharvaya Metals Preferential Issue
Sharvaya Metals corrected its EGM notice on preferential issues of swap shares and warrants, totalling Rs 11.68 Crore. It updates disclosures before the November 6 meeting.
- Value
- ₹11.68 Cr